scholarly journals Use Of Real-World Data To Estimate Cardiovascular Event Rates Among Elderly High Cardiovascular Risk Patients With Medicare Supplemental Insurance In The United States

2016 ◽  
Vol 19 (3) ◽  
pp. A11
Author(s):  
RG Quek ◽  
J Hardin ◽  
MM Bonafede ◽  
BH Johnson ◽  
SR Gandra
Keyword(s):  
United States ◽  
Cardiovascular Risk ◽  
Cardiovascular Event ◽  
Real World ◽  
The United States ◽  
High Cardiovascular Risk ◽  
Real World Data ◽  
Supplemental Insurance ◽  
Risk Patients ◽  
Event Rates

Real-World Characteristics And Risk Of Cardiovascular Events In High Cardiovascular Risk Patients In France

2019 ◽  
Vol 287 ◽  
pp. e180
Author(s):  
G. Désaméricq ◽  
F. Fagnani ◽  
C. Emery ◽  
J. Gourmelen ◽  
J.V. Chauny ◽  
...  
Keyword(s):  
Cardiovascular Risk ◽  
Real World ◽  
Cardiovascular Events ◽  
High Cardiovascular Risk ◽  
Risk Patients

scholarly journals Estimating the Population Benefits and Costs of Rituximab Therapy in the United States from 1998 to 2013 Using Real-World Data

Medical Care ◽  
2016 ◽  
Vol 54 (4) ◽  
pp. 343-349 ◽  
Author(s):  
Mark D. Danese ◽  
Carolina M. Reyes ◽  
Michelle L. Gleeson ◽  
Marc Halperin ◽  
Sandra L. Skettino ◽  
...  
Keyword(s):  
United States ◽  
Real World ◽  
The United States ◽  
Real World Data ◽  
World Data ◽  
Benefits And Costs

scholarly journals Cost‐Effectiveness of LDL ‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

2016 ◽  
Vol 39 (6) ◽  
pp. 313-320 ◽  
Author(s):  
Shravanthi R. Gandra ◽  
Guillermo Villa ◽  
Gregg C. Fonarow ◽  
Mickael Lothgren ◽  
Peter Lindgren ◽  
...  
Keyword(s):  
United States ◽  
Cardiovascular Risk ◽  
Cost Effectiveness ◽  
The United States ◽  
High Cardiovascular Risk
Sign in / Sign up

Export Citation Format

Share Document